Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 188
Selected: 0
NCT IDTitle
NCT06107738Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
NCT00002547Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
NCT00897741Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer
NCT01698658Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer
NCT06420167DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
NCT02472275PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
NCT00002907Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
NCT02178163Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT00691015Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
NCT07095114A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NCT00258284Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
NCT03406858Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
NCT00003936Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
NCT00499694Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
NCT06339827ASk Questions in GYnecologic Oncology (ASQ-GYO)
NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT00027807Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT03683420Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment
NCT05738005Dietary Reporting in the Amyloidoses
NCT06501040Increasing Knowledge and Interest in Cancer Clinical Trials
NCT00899665Proteases in Patients With Prostate Cancer That Has Spread to the Bone
NCT02520115Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
NCT01534143High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
NCT00248560Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
NCT05028374COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
NCT00028548XK469 in Treating Patients With Advanced Solid Tumors
NCT06908629Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
NCT03684005MyPatientPal: An App to Help Patients Manage Their Cancer Care
NCT00972023DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
NCT02058706LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
NCT04159896ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
NCT00906503Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules
NCT01116232Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
NCT00056004Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
NCT00303901Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
NCT07042191A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
NCT01812668Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
NCT01609816Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
NCT03033914A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
NCT00244946Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
NCT05903092MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer
NCT02372877Evaluation of the AMICUS RBCx System in Sickle Cell Patients
NCT00004144Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
NCT01308905Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT00238329PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
NCT03750981C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)
NCT01504711Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy
NCT00014573Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
NCT009350903'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
NCT02960594hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse